These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1360 related items for PubMed ID: 19135506

  • 1. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.
    Neuroscience; 2009 Mar 03; 159(1):296-307. PubMed ID: 19135506
    [Abstract] [Full Text] [Related]

  • 2. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.
    Julien C, Tremblay C, Phivilay A, Berthiaume L, Emond V, Julien P, Calon F.
    Neurobiol Aging; 2010 Sep 03; 31(9):1516-31. PubMed ID: 18926603
    [Abstract] [Full Text] [Related]

  • 3. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
    Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lütjohann D, Hartmann T, Tanila H.
    Neurobiol Dis; 2006 Sep 03; 23(3):563-72. PubMed ID: 16765602
    [Abstract] [Full Text] [Related]

  • 4. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.
    Neuroscience; 2007 Oct 26; 149(2):286-302. PubMed ID: 17904756
    [Abstract] [Full Text] [Related]

  • 5. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Oct 26; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta.
    Takechi R, Galloway S, Pallebage-Gamarallage MM, Wellington CL, Johnsen RD, Dhaliwal SS, Mamo JC.
    Br J Nutr; 2010 Mar 26; 103(5):652-62. PubMed ID: 19860996
    [Abstract] [Full Text] [Related]

  • 7. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
    Lebbadi M, Julien C, Phivilay A, Tremblay C, Emond V, Kang JX, Calon F.
    J Alzheimers Dis; 2011 Mar 26; 27(4):853-69. PubMed ID: 21914946
    [Abstract] [Full Text] [Related]

  • 8. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
    Hooijmans CR, Rutters F, Dederen PJ, Gambarota G, Veltien A, van Groen T, Broersen LM, Lütjohann D, Heerschap A, Tanila H, Kiliaan AJ.
    Neurobiol Dis; 2007 Oct 26; 28(1):16-29. PubMed ID: 17720508
    [Abstract] [Full Text] [Related]

  • 9. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M, Shahdat HM, Yamashita S, Katakura M, Tanabe Y, Fujiwara H, Gamoh S, Miyazawa T, Arai H, Shimada T, Shido O.
    J Neurochem; 2008 Dec 26; 107(6):1634-46. PubMed ID: 19014387
    [Abstract] [Full Text] [Related]

  • 10. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Dec 26; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 11. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS.
    Neurobiol Aging; 2009 Jul 26; 30(7):1078-90. PubMed ID: 18053619
    [Abstract] [Full Text] [Related]

  • 12. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z, Dong W, Qin Y, Fei G, Zhong C, Xu TL.
    Brain; 2010 May 26; 133(Pt 5):1342-51. PubMed ID: 20385653
    [Abstract] [Full Text] [Related]

  • 13. Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canines.
    Nuntagij P, Oddo S, LaFerla FM, Kotchabhakdi N, Ottersen OP, Torp R.
    J Alzheimers Dis; 2009 May 26; 16(2):315-23. PubMed ID: 19221421
    [Abstract] [Full Text] [Related]

  • 14. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.
    Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA.
    Neurobiol Dis; 2000 Aug 26; 7(4):321-31. PubMed ID: 10964604
    [Abstract] [Full Text] [Related]

  • 15. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.
    Acta Neuropathol; 2007 Jun 26; 113(6):627-36. PubMed ID: 17431643
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.
    Sterniczuk R, Dyck RH, Laferla FM, Antle MC.
    Brain Res; 2010 Aug 12; 1348():139-48. PubMed ID: 20471965
    [Abstract] [Full Text] [Related]

  • 17. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
    Sahlin C, Pettersson FE, Nilsson LN, Lannfelt L, Johansson AS.
    Eur J Neurosci; 2007 Aug 12; 26(4):882-9. PubMed ID: 17714184
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L.
    Neurobiol Dis; 2010 Feb 12; 37(2):294-306. PubMed ID: 19781645
    [Abstract] [Full Text] [Related]

  • 19. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q, Zhang X, Sun A.
    Acta Neuropathol; 2009 Jun 12; 117(6):687-97. PubMed ID: 19190923
    [Abstract] [Full Text] [Related]

  • 20. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice.
    Hooijmans CR, Van der Zee CE, Dederen PJ, Brouwer KM, Reijmer YD, van Groen T, Broersen LM, Lütjohann D, Heerschap A, Kiliaan AJ.
    Neurobiol Dis; 2009 Mar 12; 33(3):482-98. PubMed ID: 19130883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.